J&J (JNJ) Reports Phase III Study Demonstrates IVEGA(R) SUSTENNA(TM) is Statistically Similar to RISPERDAL(R) CONSTA(R) Injection
Tweet Send to a Friend
Treatment with once-monthly INVEGA® SUSTENNA(TM) is not inferior to treatment with bi-weekly RISPERDAL® CONSTA®, according to new data from a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
